Lokavant in the News
June 11, 2024, 8:47 AM EDT
New solution supports trial feasibility prediction, optimization, and control throughout the trial
May 7, 2024, 9:57 AM EDT
New advisory board and executive hire bring domain-rich experience to Lokavant
February 5, 2024, 2:51 PM EST
New clinical trial data hub aggregates, centralizes and standardizes data across sources Lokavant, the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH),...
October 3, 2023, 10:03 AM EDT
Lokavant, the clinical trial intelligence platform company, today announces an $8 million strategic investment from global business titan Mitsui & Co. Ltd. to expand its AI-optimized platform across...
September 11, 2023, 1:42 PM EDT
As increased diversity of patient populations who participate in clinical trials becomes more entrenched as a modern business, clinical, and regulatory requirement, new trial technologies and tools...
September 5, 2023, 12:13 PM EDT
Emerging technologies are making waves in biopharma research. A recent article in Citeline In Vivo discusses how machine learning (ML) is being used to improve clinical trial diversity. By analyzing...
September 1, 2023, 2:07 PM EDT
Rohit Nambisam is CEO of Lokavant, OSP caught up with him at DIA Global in Boston earlier this summer to find out more about him and the work he is passionate about.
August 29, 2023, 9:30 AM EDT
New analytics technology reduces trial costs and timelines; initial case shows it can cut the number of sites needed for a trial by 36% Lokavant, the clinical trial intelligence platform company,...
July 13, 2023, 10:53 AM EDT
Attempts at improving diversity, equity, and inclusion (DEI) access across U.S. healthcare is a much-welcomed, if not long-overdue, development in recent years. SubstantiveDEI legislation was signed...
June 21, 2023, 4:29 PM EDT
Lokavant CEO Rohit Nambisan recently joined Jared Taylor, host of BioBreakthrough, for an enlightening conversation about the unique challenges and exciting opportunities in the field of clinical...
June 20, 2023, 5:55 PM EDT
Clinical trial participation amongst minority groups in the U.S. is woefully inadequate a challenge that has plagued this industry for years. In December 2022, substantive diversity, equity, and...
June 6, 2023, 12:09 PM EDT
Attempts at improving diversity, equity, and inclusion (DEI) access across US healthcare is a much-welcomed, if not long-overdue, development in recent years. Substantive DEI legislation was signed...
May 26, 2023, 3:10 PM EDT
In the latest episode of Brad Hightower's Note to File Podcast, Lokavant CEO Rohit Nambisan engaged in an enlightening conversation about the evolution of clinical trials. The discussion was...
May 22, 2023, 11:43 AM EDT
The year 2020 was a watershed moment for many reasons, but notably, it cast a light on the pervasive health and social inequities that have long marred the U.S. The COVID-19 pandemic hit diverse...
May 10, 2023, 11:12 AM EDT
A data-agnostic integration platform for optimizing trial planning and conduct hit the streets three years ago, bringing near-real-time insights about every participant, site, country, region, and...
April 26, 2023, 10:36 AM EDT
NEW YORK – April 26, 2023 – Lokavant, the clinical trial intelligence platform company, today announced its Product Advisory Board. This esteemed group of industry leaders will help drive the...
April 10, 2023, 5:43 PM EDT
RecentlyRohit Nambisanthe CEO of New York City-based Lokavant connected with TrialSite’s founder Daniel O’Connor for a review of the startup’s origins, emerging value proposition and directions....
April 6, 2023, 10:26 AM EDT
Lokavant is a company looking to fix the fragmentation problem in clinical trials, which has been caused by the number of trials nearly quadrupling since 2010, leading to far more data being...
April 5, 2023, 12:29 PM EDT
NEW YORK – April 4, 2023 – Lokavant, the clinical trial intelligence platform company, announces strategic new hires to drive its mission to make clinical trials smarter. Lokavant, launched in 2020,...